Navigation Links
ICOS in Medical News

Amylin Sends Letter to Shareholders

...g. In addition, this year we have put up for election two new nominees: Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation, and Paulo F. Costa, former President and Chief Executive Officer of Novartis U.S. Corporation. Both are widely respected business leader...

AAI honors Chen Dong for breakthrough T lymphocyte research

... of IL-17. "So we thought maybe IL-17 is more important than interferon-gamma in autoimmune diseases," Dong said. IL-17 also turns out to rely on the icos receptor that was missing from the T cells of the mutant mice. Paper reveals new path to autoimmune and inflammatory diseases Dong's subsequent ...

Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders

...re Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation and Paulo F. Costa, former President and Chief Executive Office...l since 2007. Prior to joining Genstar, he served in numerous capacities at icos Corporation, including Director, Chief Executive Officer, President and Cha...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

...d in the reconciliation tables and also assume the icos acquisition was completed January 1, 2007. The pro...opment charges associated with the acquisitions of icos ($303.5 million), Hypnion ($291.1 million) and Ivy... - .06 Pro forma as if the icos acquisition was completed on January 1, 2007...

Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration

...edge," explains Cami Gearhart, CEO. Prior to joining Quorum Review IRB, Mr. Malafronte directed quality groups at Nastech Pharmaceuticals, icos Corporation, and Abbott Labs. "It is a pleasure to be heading up the Quality Management and Document Administration teams at Quorum Review,"...

Lilly Caps Successful Year with Strong Fourth-Quarter Results

...he reconciliation tables below and also assume the icos acquisition was completed January 1, 2006. The pro...om the joint- venture countries prior to the icos acquisition on January 29, 2007. Total world...rtization of the intangible assets acquired in the icos acquisition, offset in part by manufacturing expen...

Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy

...es later in this press release and also assume the icos acquisition was completed January 1, 2006. For 200...he charges noted in the table below and assume the icos acquisition was completed January 1, 2006. Includi... .63 - Include pro forma as if the icos acquisition was completed (.01) (....

CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development

...s(R) pre-commercialization team created to develop icos sales force's strategy/configuration and pre-launc...activities to establish brand character. While at icos Corporation, he also secured a co-promotion agreem...ulti-million dollar co-promotion agreement for the icos sales force. He is also attributed with negotiatin...

Lilly Delivers Strong Third-Quarter Results

...he reconciliation tables below and also assume the icos acquisition was completed January 1, 2006. The pro...from the joint-venture countries prior to the icos acquisition on January 29, 2007. Total worldw... .06 - Include pro forma as if the icos acquisition was completed on January 1, 2006...

Cialis Eases Erectile Dysfunction After Spinal Cord Injury

...fects among the men who took Cialis were headache (8.5 percent) and urinary tract infection (7.7 percent). The study, funded by Cialis' maker Lilly icos LLC, was posted online Sept. 10 and is expected to be published in the November print issue of the journal Archives of Neurology . More informati...

More>>

ICOS in Medical Technology

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License

BOTHELL, Wash. and BRISBANE, Australia, May 8 /PRNewswire/ -- Implicit Bioscience Ltd and CMC ICOS Biologics today announced the execution of a manufacturing contract to support the next stage of development and commercialization of IC14, a clinical-stage monoclonal antibody for acute lung injury ...

Lilly and Glenmark Pharmaceuticals Announce License Agreement

... - .31 Include pro forma as if the icos acquisition was completed on January 1, 2006 - ... and OSI in-licensing .58 - Include pro forma as if the icos acquisition was completed on January 1, 2006 (.01) ...

Study: Identical Doses of BiDil Components Are Not Bioequivalent to the Fixed Dose Combination-BiDil-Used in A-HeFT

...f Pfizer, Inc.; Levitra is a registered trademark of Bayer HealthCare, GlaxoSmithKline, and Schering-Plough; Cialis is a registered trademark of Lilly icos LLC. About NitroMed, Inc. NitroMed of Lexington, Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil, an oral...
ICOS in Biological Technology

Oncothyreon appoints Scott Peterson as Vice President of Research and Development

...ication in oncology. From 1999 until 2007 he held a variety of positions at icos Corporation in Bothell, Washington, most recently as a Principal Scientist in Oncology Drug Discovery. At icos he was involved in both small molecule and antibody development. Dr. Peters...

ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials

...g and contract management. Before joining ClearTrial, she led the Financial Administration division for the Clinical Business Management department at icos Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis®. At ICOS, Lucas was responsible for establishing best practic...

Amylin Comments on RiskMetrics Report

...and embraced the need for change, with two new independent Director nominees, Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation, and Paulo F. Costa, former President and Chief Executive Officer of Novartis U.S. Corporation. Both bring additional commercial and oper...

Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments

...s of all our shareholders. The two new independent nominees to our Board are Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation, and Paulo F. Costa, former President and Chief Executive Officer of Novartis U.S. Corporation. Both possess valuable commercial and oper...

Implicit Licenses Clinical Stage Antibody Program From Lilly

... is an excellent opportunity, and a good fit to our capabilities and business model." IC14 had earlier been in development for severe sepsis at icos Corporation which was acquired by Lilly in 2007. It has been used in the treatment of more than 150 patients, and has well characterized safety and ph...

ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference

... and contract management. Before joining ClearTrial, she led the Financial Administration division for the Clinical Business Management department at icos Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis®. At ICOS, Lucas was responsible for establishing best practi...

MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology

...CAM-3001 is a phase 1 clinical stage program. -- icos - icos (Inducible costimulator) is a receptor on activate...ntral role in humoral immunity. Elevated levels of icos are present in patients with autoimmune disea...

Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman

...erved as an independent director of Anthera since 2006. Dr. Henney is a co-founder of three major publicly held U.S. biotechnology companies: Immunex‚ icos and Dendreon‚ and has been associated with the formation of several others. Most recently Dr. Henney has served as Chairman and Chief Executive Office...

Lilly Reports Solid Second-Quarter Results

...ales from the joint-venture countries prior to the icos acquisition on January 29, 2007. Total worldw...d IPR&D charges associated with the acquisition of icos of $303.5 million and the licensing arrangement wi... (.19) - Include pro forma as if the icos acquisition was completed on January 1, 2007...

Lilly Reports Solid First-Quarter Results

...rom the joint-venture countries prior to the icos acquisition on January 29, 2007. Total world... the acquisition of ICOS, the results of the Lilly icos joint venture were presented in other income. Subs...elopment charge associated with the acquisition of icos was not deductible. Reported net income and earn...
Other Tags
(Date:4/17/2014)... of Canadians surveyed said they would participate in public ... of genetic conditions, only 80 per cent said they ... sequence their newborns, genomes.,Most newborns in North America have ... two of life in which a tiny amount of ... about five to 54 conditions, depending on the state ...
(Date:4/17/2014)... Johnston, whose work has transformed cancer care in Northern ... European Academy of Cancer Sciences., The Academy, which was ... highly distinguished oncologists and cancer researchers which aims to ... Europe. , Professor Johnston, whose leadership has seen cancer ... of the UK league table to near the top, ...
(Date:4/17/2014)... more research to be carried out into HIV ... In a paper in The Lancet Infectious ... colleagues in the department of Parasitology and researchers ... University of Cambridge and the Royal Veterinary College ... of HIV/AIDS and schistosomiasis of children, and found ...
(Date:4/16/2014)... PHOENIX, Ariz. April 15, 2014 The Translational ... philanthropists at their annual Founders Dinner for their support ... The event took place March 28 in Scottsdale. , ... Catherine Ivy Foundation, received TGen,s John S. McCain Leadership ...
(Date:4/16/2014)... A team that includes scientists from the School of Medicine ... Antonio, Johns Hopkins University and St. Mary,s University reported the ... infect the body. , The fungal pathogen Candida albicans ... is the most common fungal pathogen to infect humans. It ...
Breaking Medicine News(10 mins):Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2
(Date:4/17/2014)... ideas about domestication derive from Charles Darwin, whose ... animal-breeding practices during the 19th century, a period ... , It is from Darwin that we inherit ... animals from wild species and total human control ... management in this industrial setting has been applied ...
(Date:4/16/2014)... State University researchers have identified a new syndrome called ... and muscle mass with obesity. , "It used to ... better your bones would be because the bones were ... Professor of Nutrition at Florida State. "But, that,s only ...
(Date:4/16/2014)... Nicolas Doucet of the Centre INRSInstitut Armand-Frappier has just received ... in the amount of nearly US$600,000. The 5-year grant is ... called RNases and to explore their biomedical potential in the ... , "Receiving a grant at this level is ...
Breaking Biology News(10 mins):The story of animal domestication retold 2The story of animal domestication retold 3The story of animal domestication retold 4Researchers: Obesity can amplify bone and muscle loss 2High-level NIH grant goes to professor Nicolas Doucet of INRS 2
Other Contents